At Maria Norte, high-grade silver mineralization has been visually confirmed at surface, providing clear and direct targets for planned initial access. Blasting and explosive permits are required to ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.26, expectations were $1.17.

The healthcare giant just took a major step that could reshape its MedTech business and boost its dividend track record.

Welcome to my first contribution to Solar Power World, part of a new series of articles looking specifically at U.S. solar ...

By Taylor Williams The industry adage that “every deal is different” has never been an exaggeration or cop-out excuse for ...